StonvexLoading…
StonvexStonvexStonvexCore line items from CRMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $311.71M | $43.47M | $65.41K | $190.94K |
Operating Income | $150.14M | $-22.36M | $-30.62M | $-29.44M |
Net Income | $163.06M | $-17.93M | $-29.70M | $-28.21M |
EPS (Diluted) | $2.04 | $-0.30 | $-0.74 | $-0.75 |
Total Assets | $826.14M | $118.85M | $62.04M | $68.95M |
Total Liabilities | $420.83M | $34.19M | $6.98M | $6.15M |
Cash & Equivalents | $144.84M | $40.65M | $43.15M | $53.32M |
Free Cash Flow OCF − CapEx | $172.79M | $-50.73M | $-24.58M | $-22.58M |
Shares Outstanding | 79.26M | 64.41M | 42.82M | 38.09M |